ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

NAMS NewAmsterdam Pharma Company NV

18.02
0.79 (4.59%)
21 Jun 2024 - Closed
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End
EUR (€)
Total Revenue
Operating Income
Pre Tax Income
Net Income
Preferred Dividends
Basic Earnings Per Share (EPS)
EBIT
EBITDA
Year End 31 December 2023 2023
EUR (€)
Total Revenue 14.09M
Operating Income -182.69M
Pre Tax Income -176.91M
Net Income -176.94M
Preferred Dividends 0
Basic Earnings Per Share (EPS) -2.145
EBIT -182.69M
EBITDA -182.64M